|
1st Drug List Your guide to 1500+ drugs online! Bookmark 1stDrugList.com |
Solu Cortef Side Effects, and Drug Interactions - Hydrocortisone sodium succinate
SIDE EFFECTS
|
|
|
|
Fluid and Electrolyte Disturbances |
|
|
Sodium retention Fluid retention Congestive heart failure in susceptible patients |
Potassium loss Hypokalemic alkalosis Hypertension |
|
Musculoskeletal |
|
|
Muscle weakness Steroid myopathy Loss of muscle mass Osteoporosis Tendon rupture, particularly of the Achilles tendon |
Vertebral compression fractures Aseptic necrosis of femoral and humeral heads Pathologic fracture of long bones |
|
Gastrointestinal |
|
|
Peptic ulcer with possible perforation and hemorrhage Pancreatitis Abdominal distention Ulcerative esophagitis |
Increases in alanine transaminase (ALT, SGPT), aspartate transaminase (AST, SGOT) and alkaline phosphatase have been observed following corticosteroid treatment. These changes are usually small, not associated with any clinical syndrome and are reversible upon discontinuation. |
|
Dermatologic |
|
|
Impaired wound healing Thin fragile skin Petechiae and ecchymoses |
Facial erythema Increased sweating May suppress reactions to skin tests |
|
Neurological |
|
|
Convulsions Increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment |
Vertigo Headache |
|
Endocrine |
|
|
Menstrual irregularities Development of Cushingoid state Suppression of growth in children Secondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery, or illness |
Decreased carbohydrate tolerance Manifestations of latent diabetes mellitus Increased requirements of insulin or oral hypoglycemic agents in diabetics |
|
Ophthalmic |
|
|
Posterior subcapsular cataracts Increased intraocular pressure |
Glaucoma Exophthalmos |
|
Metabolic |
|
|
Negative nitrogen balance due to protein catabolism |
|
|
The following additional reactions are related to parenteral corticosteroid therapy: |
|
|
Allergic, anaphylactic or other hypersensitivity reactions Hyperpigmentation or hypopigmentation |
Subcutaneous and cutaneous atrophy Sterile abscess |
DRUG INTERACTIONS
The pharmacokinetic interactions listed below are potentially clinically important. Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance. Therefore, the dose of corticosteroid should be titrated to avoid steroid toxicity. Corticosteroids may increase the clearance of chronic high dose aspirin. This could lead to decreased salicy-late serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn. Aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia. The effect of corticosteroids on oral anticoagulants is variable. There are reports of enhanced as well as diminished effects of anticoagulants when given concurrently with corticosteroids. Therefore, coagulation indices should be monitored to maintain the desired anticoagulant effect.
top| Popular Searches: | ||||
![]() weight loss |
![]() ultram |
![]() penis enlargement |
![]() hydrocodone |
![]() antibiotic |